chr4-75012797-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015393.4(PARM1):c.416C>T(p.Ser139Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015393.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARM1 | NM_015393.4 | c.416C>T | p.Ser139Leu | missense_variant | 2/4 | ENST00000307428.7 | NP_056208.2 | |
PARM1 | XM_011531833.1 | c.521C>T | p.Ser174Leu | missense_variant | 3/5 | XP_011530135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARM1 | ENST00000307428.7 | c.416C>T | p.Ser139Leu | missense_variant | 2/4 | 1 | NM_015393.4 | ENSP00000370224.3 | ||
PARM1 | ENST00000513238.5 | c.44-21086C>T | intron_variant | 3 | ENSP00000424276.1 | |||||
ENSG00000248165 | ENST00000513770.1 | n.52-13626G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248970Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135062
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461700Hom.: 0 Cov.: 55 AF XY: 0.00000963 AC XY: 7AN XY: 727132
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.416C>T (p.S139L) alteration is located in exon 2 (coding exon 2) of the PARM1 gene. This alteration results from a C to T substitution at nucleotide position 416, causing the serine (S) at amino acid position 139 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at